[ad_1]
MEXICO CITY (Expansion) –
Siemens Healthineers, a division of Siemens Medical Technology, today presented its Atellica Solution team, which can perform analyzes for 440 samples in one hour for 170 types of devices. Clinical trials, such as allergies, diabetes, cholesterol, sepsis, kidney disease, thyroid and others.
The development of this laboratory equipment – which can work with three modules of analysis and reach up to 10 components – is part of the annual investment of the German company of 1 000 million euros (mde) in the Siemens Healthineers sector.
"Health systems face a series of challenges that are viable and economically viable, we facilitate health service providers with better-performing solutions, lower cost results," said Alejandro Paolini, CEO of Siemens Healthineers Mexico, Central America and the Caribbean.
Lee: It's the Due to the growth and aging of the population, as well as new diseases to diagnose, precision medicine helps to quality and immediate results, says Dulce Reyes, director of diagnostic and laboratory field.
"Laboratories have more tests in the same square meters and we have fewer graduates from specialized careers. The technology we present today allows laboratories to be 10 times faster and more efficient, "said Reyes.
Atellica performs 94% of the most common tests in a hospital with 170 tests that you can do with only one blood sample and the results are delivered in 10 minutes, while in the usual procedure took up to 30 minutes.
Lee: C & # 39; is the Mexican laboratory that wants to conquer the EU
"Digitization plays a fundamental role so that our health systems can have better results with lower costs and increase productivity," Paolini said. Atellica's team is working with cameras that identify test tube barcodes and distribute the priority type of analysis to deliver it in less than 10 minutes to a complete process at the room. 39, operation, if necessary [19659003] The first place in Mexico where you can test the effectiveness of this equipment for medical testing is at Dr. Moreira Laboratories in Monterrey. The team is already present in Europe, Asia, the United States and South America
Source link
